Tyra Biosciences
TYRA
62 hedge funds and large institutions have $496M invested in Tyra Biosciences in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 6 closing their positions.
75% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 12
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
5% more funds holding
Funds holding: 59 → 62 (+3)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1% less capital invested
Capital invested by funds: $502M → $496M (-$6.44M)
1.66% less ownership
Funds ownership: 84.78% → 83.12% (-1.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$4.4M |
| 2 |
5VM
5AM Venture Management
San Francisco,
California
|
+$1.86M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$1.77M |
| 4 |
BlackRock
New York
|
+$888K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$689K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$14.6M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$5.65M |
| 3 |
AGP
Artia Global Partners
Miami,
Florida
|
-$453K |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$439K |
| 5 |
PL
Parkwood LLC
Cleveland,
Ohio
|
-$234K |
TYRA Hedge Fund Activity: Q4 2023 in Review
62 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Tyra Biosciences (TYRA) for Q4 2023, worth a combined $496M — down 1.3% from $502M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new TYRA positions and 6 closed out — a net gain of 3 holders — while 21 added to existing stakes and 12 trimmed.
The largest buyer was Kynam Capital Management, opening a new position worth an estimated $4.4M. The largest seller was Fidelity Investments, cutting an estimated $14.6M.
- 62 institutional investors held Tyra Biosciences (TYRA) as of Q4 2023, up from 59 in Q3 2023.
- Funds reported $496M of Tyra Biosciences stock for Q4 2023, down 1.3% quarter-over-quarter.
- 9 funds opened new Tyra Biosciences positions in Q4 2023 and 6 closed out, a net change of +3 holders.
- The largest Tyra Biosciences buyer in Q4 2023 was Kynam Capital Management, an estimated $4.4M added.
- The largest Tyra Biosciences seller in Q4 2023 was Fidelity Investments, an estimated $14.6M sold.
Based on aggregated 13F filings for Q4 2023.